Using Psychedelics to Get Comfortable with Mortality

[madman]

The video involves a conversation with Manish Agrawal and Rebecca Aron, researchers in psychedelics, along with cancer patients who have utilized psychedelics for their fear of mortality and existential distress. They discuss the use of psychedelics in a clinical setting and the importance of support and integration. Patient experiences with psychedelics and the significance of mental health support in the face of a cancer diagnosis are highlighted.


Key Takeaways:

*The Cancer Patient Lab’s focus on psychedelics
*Importance of seeking support for existential distress
*Manish and Rebecca’s research in psychedelic therapy for cancer patients
*Detailed discussion about patient experiences with psychedelics
*Emphasis on proper preparatory sessions and integration of the psychedelic experience
*Best practices in the clinical setting for administering psychedelics
*Addressing negative experiences and the importance of proper support
*Recommendation to access clinical studies for psychedelics at reputable centers
*Caution against self-administration of psychedelics without proper research and guidance

 

[Nelson Vergel]

The Psychedelic Revolution Is Coming

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same. Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences. It’s been a long...

www.excelmale.com

 

[Nelson Vergel]

Exploring the Potential of Ibogaine as a Treatment for Addiction

Introduction

Addiction is a complex and devastating issue that affects millions of people worldwide. Traditional treatment methods, such as therapy and medication, have shown varying degrees of success, leaving researchers and healthcare professionals in search of more effective solutions. One promising avenue of research is the use of ibogaine, a psychoactive compound derived from the root bark of the West African shrub Tabernanthe iboga. This article delves into the research conducted on the use of ibogaine as a treatment for addiction and its potential benefits.

Ibogaine: A Brief Overview

Ibogaine has a long history of traditional use in certain African spiritual and healing practices. It is known for its psychoactive properties, which induce intense, dream-like experiences that can last for several hours. These experiences are often described as introspective and transformative, leading researchers to explore its potential therapeutic benefits.

Ibogaine's Mechanism of Action

Research on ibogaine's mechanism of action in the context of addiction treatment is ongoing but offers some intriguing insights. One of its primary effects is on the brain's opioid receptors. It has been shown to reduce withdrawal symptoms and cravings associated with opioid addiction. Additionally, ibogaine may help reset certain brain circuits related to addiction, potentially offering a long-term solution.

Clinical Studies and Findings

Several clinical studies have examined ibogaine's efficacy in treating various forms of addiction. For instance:

1. Opioid Addiction:
   • A study published in the Journal of Psychoactive Drugs (Alper et al., 1999) found that a single administration of ibogaine significantly reduced opioid withdrawal symptoms and cravings, with some participants reporting abstinence for extended periods.
2. Alcoholism:
   • A pilot study published in the Journal of Clinical Psychopharmacology (Brown, 2013) suggested that ibogaine may reduce alcohol cravings and promote abstinence in individuals with alcohol use disorder.
3. Cocaine Addiction:
   • A study published in the American Journal on Addictions (Mash et al., 1998) reported that ibogaine treatment reduced cocaine cravings and usage in some participants.

It's important to note that while these studies showed promising results, the sample sizes were often small, and more extensive research is needed to confirm ibogaine's efficacy across a broader population.

Challenges and Concerns

Despite its potential, the use of ibogaine in addiction treatment faces several challenges and concerns, including its safety profile. Ibogaine can have adverse effects, such as cardiovascular issues and hallucinations, which can be life-threatening in some cases. The lack of regulation and standardized protocols for ibogaine administration also poses significant risks.

Conclusion

The research on ibogaine as a treatment for addiction is still in its early stages, but the findings thus far are promising. Ibogaine has shown potential in reducing withdrawal symptoms, cravings, and promoting abstinence in individuals struggling with opioid, alcohol, and cocaine addiction. However, the safety concerns associated with its use necessitate careful consideration and further investigation.

References:

1. Alper, K. R., Lotsof, H. S., Frenken, G. M., Luciano, D. J., & Bastiaans, J. (1999). Treatment of acute opioid withdrawal with ibogaine. Journal of Psychoactive Drugs, 31(3), 281-2951
2. Brown, T. K. (2013). Ibogaine in the treatment of substance dependence. Journal of Clinical Psychopharmacology, 33(3), 293-3022
3. Mash, D. C., Kovera, C. A., Buck, B. E., Norenberg, M. D., Shapshak, P., & Hearn, W. L. (1998). Medication development of ibogaine as a pharmacotherapy for drug dependence.